Resultados de procura - Cierra N. Sharp
- Mostrando 1 - 5 Resultados de 5
-
1
-
2
-
3
C57BL/6 mice require a higher dose of cisplatin to induce renal fibrosis and CCL2 correlates with cisplatin-induced kidney injury por Sophia M. Sears, Cierra N. Sharp, Austin Krueger, Gabrielle B. Oropilla, Douglas Saforo, Mark A. Doll, Judit Megyesi, Levi J. Beverly, Leah J. Siskind
Publicado 2020Artigo -
4
-
5
Inhibiting glucosylceramide synthase exacerbates cisplatin-induced acute kidney injury por Tess V. Dupre, Mark A. Doll, Parag P. Shah, Cierra N. Sharp, Deanna Siow, Judit Megyesi, James A. Shayman, Alicja Bielawska, Jacek Bielawski, Levi J. Beverly, María José Hernandez‐Corbacho, Christopher J. Clarke, Ashley J. Snider, Rick G. Schnellmann, Lina M. Obeid, Yusuf A. Hannun, Leah J. Siskind
Publicado 2017Artigo
Ferramentas de procura:
Materias Relacionadas
Chemotherapy
Cisplatin
Internal medicine
Medicine
Pharmacology
Kidney
Acute kidney injury
Fibrosis
Kidney disease
Dosing
Glomerulosclerosis
Nephrotoxicity
Pathology
Proteinuria
Regimen
Administration (probate law)
Apoptosis
Biochemistry
Biology
Cancer research
Ceramide
Chemistry
Endocrinology
Enzyme
Immunology
Inflammation
Intensive care medicine
Lactosylceramide
Law
Oncology